Literature DB >> 15000735

Sulfadoxine-pyrimethamine remains efficacious against uncomplicated, Plasmodium falciparum malaria in north-eastern Afghanistan.

N Ezard1, P Nellepalli, A W Asha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15000735     DOI： 10.1179/000349804225003019

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  6 in total

1.  Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.

Authors:  Ghulam Rahim Awab; Sasithon Pukrittayakamee; Mallika Imwong; Arjen M Dondorp; Charles J Woodrow; Sue Jean Lee; Nicholas P J Day; Pratap Singhasivanon; Nicholas J White; Faizullah Kaker
Journal:  Malar J       Date:  2010-04-21       Impact factor: 2.979

2.  Clinical trial of extended-dose chloroquine for treatment of resistant falciparum malaria among Afghan refugees in Pakistan.

Authors:  Natasha Howard; Naeem Durrani; Sanda Sanda; Khalid Beshir; Rachel Hallett; Mark Rowland
Journal:  Malar J       Date:  2011-06-23       Impact factor: 2.979

3.  Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP.

Authors:  Kate Kolaczinski; Toby Leslie; Iftikhar Ali; Naeem Durrani; Sue Lee; Marion Barends; Khalid Beshir; Rosalynn Ord; Rachel Hallett; Mark Rowland
Journal:  PLoS One       Date:  2012-01-31       Impact factor: 3.240

4.  Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.

Authors:  Ghulam Rahim Awab; Mallika Imwong; Sasithon Pukrittayakamee; Fazel Alim; Warunee Hanpithakpong; Joel Tarning; Arjen M Dondorp; Nicholas P J Day; Nicholas J White; Charles J Woodrow
Journal:  Malar J       Date:  2016-02-25       Impact factor: 2.979

5.  An unlabelled probe-based real time PCR and modified semi-nested PCR as molecular tools for analysis of chloroquine resistant Plasmodium vivax isolates from Afghanistan.

Authors:  Sayed Hussain Mosawi; Abdolhossein Dalimi; Najibullah Safi; Reza Fotouhi-Ardakani; Fatemeh Ghaffarifar; Javid Sadraei
Journal:  Malar J       Date:  2020-07-14       Impact factor: 2.979

6.  Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.

Authors:  Ghulam R Awab; Sasithon Pukrittayakamee; Natsuda Jamornthanyawat; Fazel Yamin; Arjen M Dondorp; Nicholas Pj Day; Nicholas J White; Charles J Woodrow; Mallika Imwong
Journal:  Malar J       Date:  2013-03-15       Impact factor: 2.979
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.